{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:29:09Z","timestamp":1794857349854,"version":"4.9.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01750","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T11:20:54Z","timestamp":1597404054000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations"],"prefix":"10.3389","volume":"11","author":[{"given":"Samantha","family":"Zottnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessa L.","family":"Vo\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika B.","family":"Riemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"pky045","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"De Sanjose","year":"2018","journal-title":"JNCI Cancer Spectr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"De Martel","year":"2017","journal-title":"Int J Cancer."},{"key":"B3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pvr.2017.12.006","article-title":"Therapeutic vaccines for high-risk HPV-associated diseases","volume":"5","author":"Chabeda","year":"2018","journal-title":"Papillomavirus Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"Zur Hausen","year":"2002","journal-title":"Nat Rev Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","article-title":"Mechanisms of human papillomavirus-induced oncogenesis","volume":"78","author":"M\u00fcnger","year":"2004","journal-title":"J Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1128\/JVI.67.12.6929-6936.1993","article-title":"Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles","volume":"67","author":"Kirnbauer","year":"1993","journal-title":"J Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1016\/j.vaccine.2006.06.005","article-title":"Enhanced humoral and memory B cellular immunity using HPV16\/18 L1 VLP vaccine formulated with the MPL\/aluminium salt combination (AS04) compared to aluminium salt only","volume":"24","author":"Giannini","year":"2006","journal-title":"Vaccine."},{"key":"B10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/978-981-10-8456-0_16","article-title":"Protein complexes and virus-like particle technology","volume":"88","author":"Zeltins","year":"2018","journal-title":"Subcell Biochem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ajog.2016.02.021","article-title":"Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment","volume":"215","author":"Hildesheim","year":"2016","journal-title":"Am J Obstet Gynecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/vaccines2020422","article-title":"Therapeutic vaccine strategies against human papillomavirus","volume":"2","author":"Khallouf","year":"2014","journal-title":"Vaccines."},{"key":"B13","doi-asserted-by":"publisher","first-page":"F71","DOI":"10.1016\/j.vaccine.2012.05.091","article-title":"Therapy of human papillomavirus-related disease","volume":"30","author":"Stern","year":"2012","journal-title":"Vaccine."},{"key":"B14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nm1598","article-title":"Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan","volume":"13","author":"Roberts","year":"2007","journal-title":"Nat Med."},{"key":"B15","first-page":"21","article-title":"Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen","volume":"56","author":"Lin","year":"1996","journal-title":"Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1158\/0008-5472.CAN-07-0321","article-title":"Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system","volume":"67","author":"Berraondo","year":"2007","journal-title":"Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/eji.1830230929","article-title":"Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells","volume":"23","author":"Feltkamp","year":"1993","journal-title":"Eur J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.virusres.2017.04.001","article-title":"HPV-transgenic mouse models: tools for studying the cancer-associated immune response","volume":"235","author":"Santos","year":"2017","journal-title":"Virus Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.virusres.2016.12.004","article-title":"Recent advances in preclinical model systems for papillomaviruses","volume":"231","author":"Christensen","year":"2017","journal-title":"Virus Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00262-012-1382-6","article-title":"BiVax: a peptide\/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses","volume":"62","author":"Cho","year":"2013","journal-title":"Cancer Immunol Immunother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/sj.gt.3302607","article-title":"Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice","volume":"13","author":"Peng","year":"2006","journal-title":"Gene Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1084\/jem.170.4.1091","article-title":"Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response","volume":"170","author":"Irwin","year":"1989","journal-title":"J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.96.18.10338","article-title":"Mice lacking all conventional MHC class II genes","volume":"96","author":"Madsen","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1002\/eji.200425463","article-title":"A mouse model of human adaptive immune functions: HLA-A2","volume":"34","author":"Pajot","year":"2004","journal-title":"Eur J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00262-007-0331-2","article-title":"HAGE, a cancer\/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I\/II HAGE-derived immunogenic peptides","volume":"56","author":"Mathieu","year":"2007","journal-title":"Cancer Immunol Immunother."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-14906-1","volume-title":"Immunology of the Female Genital Tract","author":"Weissenbacher","year":"2014"},{"key":"B28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.it.2018.01.007","article-title":"Immunology of the uterine and vaginal mucosae","volume":"39","author":"Zhou","year":"2018","journal-title":"Trends Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1158\/1078-0432.CCR-14-3341","article-title":"Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6","volume":"21","author":"Draper","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1200\/JCO.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells","volume":"33","author":"Stevanovic","year":"2015","journal-title":"J Clin Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1200\/JCO.18.02424","article-title":"T-cell receptor gene therapy for human papillomavirus-associated epithelial cancers: a first-in-human, phase I\/II Study","volume":"37","author":"Doran","year":"2019","journal-title":"J Clin Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ygyno.2019.12.017","article-title":"Current status of therapeutic HPV vaccines","volume":"156","author":"Clark","year":"2020","journal-title":"Gynecol Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"155ra138","DOI":"10.1126\/scitranslmed.3004414","article-title":"Immunotherapy against HPV16\/18 generates potent TH1 and cytotoxic cellular immune responses","volume":"4","author":"Bagarazzi","year":"2012","journal-title":"Sci Transl Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1080\/21645515.2019.1695459","article-title":"Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population","volume":"16","author":"Hollenberg","year":"2020","journal-title":"Hum Vaccin Immunother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0172821","DOI":"10.1371\/journal.pone.0172821","article-title":"Tissue-specific regulation of CXCL9\/10\/11 chemokines in keratinocytes: implications for oral inflammatory disease","volume":"12","author":"Marshall","year":"2017","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nature08511","article-title":"CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help","volume":"462","author":"Nakanishi","year":"2009","journal-title":"Nature."},{"key":"B38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2016.11.011","article-title":"Tissue resident memory T cells and viral immunity","volume":"22","author":"Rosato","year":"2017","journal-title":"Curr Opin Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1128\/IAI.01484-07","article-title":"Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer","volume":"76","author":"Echchannaoui","year":"2008","journal-title":"Infect Immun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/ijc.24949","article-title":"Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice","volume":"126","author":"Decrausaz","year":"2010","journal-title":"Int J Cancer."},{"key":"B42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ijc.25973","article-title":"Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors","volume":"129","author":"Decrausaz","year":"2011","journal-title":"Int J Cancer."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1172\/JCI63287","article-title":"Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses","volume":"122","author":"\u00c7uburu","year":"2012","journal-title":"J Clin Invest."},{"key":"B44","doi-asserted-by":"publisher","first-page":"172ra120","DOI":"10.1126\/scitranslmed.3004888","article-title":"Mucosal imprinting of vaccine-induced CD8(+) T cells is crucial to inhibit the growth of mucosal tumors","volume":"5","author":"Sandoval","year":"2013","journal-title":"Sci Transl Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1164363","DOI":"10.1080\/2162402X.2016.1164363","article-title":"Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles","volume":"5","author":"Macedo","year":"2016","journal-title":"Oncoimmunology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature."},{"key":"B47","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.it.2015.07.002","article-title":"Tissue instruction for migration and retention of TRM cells","volume":"36","author":"Iijima","year":"2015","journal-title":"Trends Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.4049\/jimmunol.1900462","article-title":"Cutting edge: the use of topical aminoglycosides as an effective pull in \u201cPrime and Pull\u201d vaccine strategy","volume":"204","author":"Gopinath","year":"2020","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mi.2012.83","article-title":"Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice","volume":"6","author":"Domingos-Pereira","year":"2013","journal-title":"Mucosal Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-14-0344","article-title":"Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNgamma","volume":"20","author":"Soong","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41541-019-0129-1","article-title":"Successful application of prime and pull strategy for a therapeutic HSV vaccine","volume":"4","author":"Bernstein","year":"2019","journal-title":"NPJ Vaccines."},{"key":"B52","doi-asserted-by":"publisher","first-page":"8316","DOI":"10.1128\/JVI.00781-11","article-title":"Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge","volume":"85","author":"Tan","year":"2011","journal-title":"J Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/mi.2017.89","article-title":"Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime-boost immunization","volume":"11","author":"Tan","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/ijc.31166","article-title":"Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8(+) T cell responses against HPV16 oncoproteins","volume":"142","author":"\u00c7uburu","year":"2018","journal-title":"Int J Cancer."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4049\/jimmunol.1800219","article-title":"A prime-pull-amplify vaccination strategy to maximize induction of circulating and genital-resident intraepithelial CD8(+) memory T cells","volume":"202","author":"\u00c7uburu","year":"2019","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/hum.2007.038","article-title":"Monitoring the trafficking of adoptively transferred antigen- specific CD8-positive T cells in vivo, using noninvasive luminescence imaging","volume":"18","author":"Kim","year":"2007","journal-title":"Hum Gene Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/ijc.25561","article-title":"A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers","volume":"128","author":"Decrausaz","year":"2011","journal-title":"Int J Cancer."},{"key":"B58","doi-asserted-by":"publisher","first-page":"22509","DOI":"10.1038\/srep22509","article-title":"Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours","volume":"6","author":"Bialkowski","year":"2016","journal-title":"Sci Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1629259","DOI":"10.1080\/2162402X.2019.1629259","article-title":"HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory","volume":"8","author":"Grunwitz","year":"2019","journal-title":"Oncoimmunology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1002\/ijc.31240","article-title":"Mouse model of postsurgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer","volume":"142","author":"Mermod","year":"2018","journal-title":"Int J Cancer."},{"key":"B61","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4161\/hv.23232","article-title":"Immunotherapy in new pre-clinical models of HPV-associated oral cancers","volume":"9","author":"Paolini","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1073\/pnas.86.5.1563","article-title":"Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice","volume":"86","author":"Vassar","year":"1989","journal-title":"Proc Natl Acad Sci USA."},{"key":"B63","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S1470-20450970227-X","article-title":"Development of therapeutic HPV vaccines","volume":"10","author":"Trimble","year":"2009","journal-title":"Lancet Oncol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgaa027","article-title":"Cooperation of genes in HPV16 E6\/E7-dependent cervico-vaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens","author":"B\u00f6ttinger","year":"2020","journal-title":"Carcinogenesis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1524694","DOI":"10.1080\/2162402X.2018.1524694","article-title":"Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model","volume":"8","author":"Kruse","year":"2019","journal-title":"Oncoimmunology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature13387","article-title":"A vaccine targeting mutant IDH1 induces antitumour immunity","volume":"512","author":"Schumacher","year":"2014","journal-title":"Nature."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T09:39:23Z","timestamp":1597916363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2020.01750"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01750","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2020.01750.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2020.01750.s002","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"article-number":"1750"}}